VeriMomIst dihydroquercetin pentacaprylate in der Schwangerschaft sicher?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
Related ingredients
Frequently asked questions
- Ist dihydroquercetin pentacaprylate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
- Ist dihydroquercetin pentacaprylate während des Stillens sicher?
- No data specific to lactation or breastmilk transfer for the pentacaprylate or parent dihydroquercetin were located. Because there is no evidence of reproductive toxicity or endocrine disruption for the parent and no harmonised flags, hazard and mechanism remain 0. Exposure from topical cosmetic use was not shown to be high. No SCCS/CIR contraindication found.
- Ist dihydroquercetin pentacaprylate sicher für Babyhaut?
- Hazard/mechanism: no infant‑specific reproductive or developmental hazard data were found for this derivative or for taxifolin; peer‑reviewed work shows taxifolin is not a reproductive teratogen and can be protective in rodent models, so h/m remain 0. Exposure: no dermal absorption data for the pentacaprylate were located. Per instructions, when adult topical absorption evidence is lacking but the ingredient is not absolutely non‑absorbable, increase baby exposure by +1 due to higher baby surface‑area:body‑weight and immature barrier.
- Wie bewertet VeriMom dihydroquercetin pentacaprylate?
- VeriMom bewertet dihydroquercetin pentacaprylate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu dihydroquercetin pentacaprylate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu dihydroquercetin pentacaprylate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.